22 May 2013
Keywords: Dyax, CMIC, Escallantide, DX-88, Japan, Licensing
Article | 01 October 2010
USA-based Dyax Corp (Nasdaq: DYAX) has entered into an agreement with Japanese firm CMIC Co (TSE: CMIC) announced to develop ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 October 2010
30 September 2010
© 2013 thepharmaletter.com